<img alt="" src="https://secure.lote1otto.com/219869.png" style="display:none;">
Skip to content

Synthetic Control Arms: Leveraging Real-World Data for Comparison in Single-Arm Trials

Weekend Read_banner

Single-arm trials, unlike placebo-controlled randomized control trials, forgo the use of a placebo or standard-of-care as a control and establish clinical benefit by demonstrating the effects of a new therapy or treatment via comparison with a synthetic control arm (SCA) derived from external sources. This alternative approach leverages real-world data from various sources or evaluations of historical trial data for the sake of comparison. The use of SCA has enabled investigators to leverage combined data from uncontrolled single-arm trials and post-market studies to create much smaller trials.

Our newly updated eBook, “Demystifying Synthetic Control Arms,” delves into this topic and covers:

  • An introduction to synthetic control arms
  • Propensity scoring methods
  • Bayesian dynamic borrowing
  • A case study on non-small cell lung cancer
  • Questions to ask if you are considering a choice between placebo-controlled and single-arm trials

To download the complimentary eBook, click below:


Download Publication

The Weekend Read series features complimentary publications on a variety of topics on clinical trial design and data science. Subscribe to our weekly newsletter below and never miss a post!

Read more from Perspectives on Enquiry and Evidence:

Sorry no results please clear the filters and try again

FDA Guidance on the Design and Conduct of Externally Controlled Trials — What to Watch

The U.S. FDA has recently provided specific guidance[i] on the design and conduct of trials incorporating an external..
Read more

Developing Synthetic Control Arms Using Bayesian Models

A new trend has emerged over the last decade that has changed the way many clinical trials are conducted. Unlike..
Read more

Adaptive Multi-Arm Multi-Stage Designs: A Comparison of Methods

Written by Cyrus Mehta and Heather Struntz The significant time and cost, as well as high failure rates, of clinical..
Read more
contact iconSubscribe back to top